Feed SOLV
SO

Solventum

SOLV · NYSE

$88.86 +1.52% (+$1.33)
1M -2.64%
Market Cap $15.4B
P/E Ratio 10.73x
Div. Yield -
ROE 28.96%
Piotroski F-Score Strong
7/9
Valuation
90 /100
Cheap
P/E 10.73x
EV/EBITDA 7.80x
P/S 1.85x
Growth
28 /100
Declining
EPS growth 4.46%
Rev. growth 0.79%
Book val. growth 24.52%
Profitability
69 /100
Strong
Gross margin 54.69%
Net margin 17.26%
Op. margin 24.99%
Quality
84 /100
Excellent
ROIC 15.85%
ROE 28.96%
ROA 10.07%
Debt
57 /100
Moderate
Debt/Equity 1.10x
Current ratio 1.02x
Int. coverage 7.38x
Stability
67 /100
Stable
Beta 0.69x
Rev. volatility 0.09%
EPS volatility 150.17%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SOLV
Online

O podjetju

Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Bryan C. Hanson

Employees

20,584

Headquarters

Eagan

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

45d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.